_edited.png)
_edited.png){kind=small}
CMCN
The Canadian Medical Cannabis Trials Network (CMCN) is a national platform to optimize the efficiency of conducting high-quality clinical trials of medical cannabis or cannabis-based medicines.
The network’s activities, infrastructure, and resources will accelerate generation of reliable evidence on the efficacy and safety of cannabinoid products for a range of health conditions.
.png)
Our Network
The Need
One in eight Canadian adults use medical cannabis but the vast majority of indications lack high-quality evidence to support its use. This evidence gap means clinicians cannot properly advise their patients whether and how to use medical cannabis products, and patients must rely on low-quality information which may result in higher-risk use and adverse effects.
​
The Canadian Medical Cannabis Clinical Trials Network will address this knowledge gap by supporting high-quality, rigorous trials of medical cannabis products thereby producing urgently needed evidence and across for clinicians, patients, and policy makers.
%20(16).png)
Our Vision
To bring together Canadian clinicians and scientists with a track record of conducting RCTs of medical cannabis across a range of indications to leverage shared knowledge, resources, and infrastructure in order to vastly expand capacity to conduct high-quality medical cannabis RCTs across Canada.
What We Do
-
Identify established and new potential trial sites
-
Share standard operating procedures (SOPs)
-
Identify producers of research-grade cannabis-based products
-
Identify and connect researchers with sites capable of conducting chemical analysis, metabolomics, and imaging
-
Conduct twice-yearly events (1 virtual, 1 in-person)
Peer Review & Grant Writing Support: Network members have the opportunity to give a presentation proposing a cannabis-related RCT. Following each presentation, members will discuss the RCT’s scientific and pragmatic merits and potential pitfalls, provide anonymous written feedback, and vote on whether the RCT should be supported by the network.
_edited.png)
Our Partners
We extend our sincere thanks to the following for their financial contributions to the network.
%20(18).png)
We take an equity, diversity, inclusion, and accessibility (EDIA) approach in everything we do. This includes free and open network membership, and ensuring EDIA best practices are implemented in all trial activities – most importantly, in the clinical trials we develop and support. An important part of this approach is centring the voices and experiences of persons with lived experience (PWLE).
%20(17).png)
​CMCN members are grateful for the privilege to work and live on treaty lands and territory of numerous Indigenous nations across Canada. We are committed to respecting and upholding the rights-based self-determination of Indigenous Peoples and to taking concrete actions towards meaningful reconciliation.​​​​